Omega Advisors Inc. is a New York-based hedge fund founded by one of the most respected figures in the investment business, Leon Cooperman.
Keep Reading →
June 1 - Hedge Funds, News
AQR Capital Management LLC was founded in 1998 by former Goldman Sachs portfolio manager Cliff Asness.
Keep Reading →
May 31 - Hedge Funds, News
Tudor Investment Corporation, the brainchild of Paul Tudor Jones, is a Greenwich, Connecticut-based hedge fund that uses a mix of fundamental and quantitative analysis accompanied...
Keep Reading →
May 28 - Hedge Fund Analysis, Hedge Funds, News
Insider Monkey strives to always keep investors updated on diverse stocks across different industries.
Keep Reading →
May 27 - Hedge Funds, News
According to a recent study by CIT, a reputable firm that is involved in financing and advisory services to the healthcare sector, healthcare executives seem rather optimistic...
Keep Reading →
May 26 - Hedge Funds, News
Kahn Brothers Advisors LLC is an Investment Advisor company providing brokerage and money management services to clients.
Keep Reading →
May 11 - Hedge Funds, News
Ken Fisher is one of the most popular American investors, Forbes columnist since 1984, and the author of the eleven investment books, four of which are New York Times Best Sellers...
Keep Reading →
May 2 - Hedge Funds, News
Billionaire Ken Fisher is the CEO of Fisher Asset Management, a fund with around $50.05 billion in equities as of the end of March. Mr.
Keep Reading →
April 30 - Hedge Funds, News
Billionaire Eric Sprott's investing reputation is rooted in precious metals.
Keep Reading →
April 27 - Hedge Funds, News
Anders Hallberg and Carl Bennet's healthcare-focused fund, Healthinvest Partners AB, recently disclosed its equity holdings in a 13F filing with the Securities and Exchange Commission...
Keep Reading →
April 24 - Hedge Funds, News
David M. Knott’s Dorset Management seems to have had an excellent start to the year.
Keep Reading →
April 17 - Hedge Funds, News
Healthcor Management LP, managed by Arthur B. Cohen and Joseph P.
Keep Reading →
April 16 - Hedge Funds, News
Kahn Brothers, managed by Alan Kahn and Thomas Kahn managed to beat the market in the first quarter of 2015, a period during which the fund’s co-founder and longtime manager...
Keep Reading →
April 13 - Hedge Funds, News
Prem Watsa’s Fairfax Financial Holdings is having a tough start for 2015.
Keep Reading →
April 9 - Hedge Funds, News
Ken Fisher’s Fisher Asset Management boasts a massive portfolio, with the fund having 422 long positions in companies with a market cap of at least $1 billion at the end of ...
Keep Reading →
April 7 - Hedge Funds, News
The first quarter of 2015 is over and before hedge funds start releasing their Form 13F filings over the next 45 days, we will take a look at the performance of the stocks they...
Keep Reading →
April 2 - Hedge Funds, News
As we are entering into the second quarter of 2015, it's time to take a brief look back and see how the market performed during the first three months of the year, and most importantly...
Keep Reading →
April 1 - Hedge Funds, News, Tech
Hal Mintz's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed with the SEC.
Keep Reading →
March 25 - Hedge Funds, News
Billionaire Ken Fisher’s Fisher Asset Management maintains a broad and diversified equity portfolio consisting primarily of long positions.
Keep Reading →
March 12 - Hedge Funds, News
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday's intraday trading and hit a 52-week high of $46.48.
Keep Reading →
March 10 - Hedge Funds, News
A popular misconception is that since these companies are in the business of finding the most value for their clients, the overwhelming experience of the fund managers, and considering...
Keep Reading →
March 6 - Hedge Funds, News
Tracking the activity of hedge funds is a great way to identify profitable investments that will help you beat the market.
Keep Reading →
March 5 - Hedge Funds, News
Arthur B. Cohen and Joseph Healey’s Healthcor Management LP recently filed its latest 13F with the SEC, disclosing its equity positions at the end of 2014.
Keep Reading →
March 2 - Hedge Funds, News
Irving Kahn, the oldest active investor on Wall Street, died this week at age 109.
Keep Reading →
February 27 - Hedge Funds, News
Toronto-based Trapeze Asset Management says Apple Inc. (NASDAQ:AAPL) is 14% overvalued according to its proprietary valuation models. Pfizer Inc.
Keep Reading →
February 26 - Hedge Funds, News, Tech
With the business of analyzing and compiling the data of our 737 tracked hedge funds’ latest 13F filings behind us, we’re ready to start sharing some of the findings from ...
Keep Reading →
February 19 - Hedge Fund Analysis, Hedge Funds, News
Animal health care company, Zoetis Inc (NYSE:ZTS) is doing extremely well according to activist investor Bill Ackman of Pershing Square, having agreed to add two members to the...
Keep Reading →
February 13 - News
Two of our tracked funds have recently revealed in filings with the SEC that they’ve taken large new passive positions in a couple of stocks.
Keep Reading →
February 10 - Hedge Funds, News
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over.
Keep Reading →
February 9 - Hedge Funds, News
Anders Hallberg and Carl Bennet’s HealthInvest Partners AB revealed its top picks for the fourth quarter of 2014. According to the 13F Form filed with the U.S.
Keep Reading →
January 25 - Hedge Funds, News
The pharmaceutical industry was the focus of intense debate earlier this year owing to potential merger between Pfizer Inc. (NYSE:PFE) and AstraZeneca plc (ADR) (NYSE:AZN).
Keep Reading →
November 26 - News
One of the sectors that has benefited from the highest returns over the years is Healthcare.
Keep Reading →
November 19 - Hedge Funds, News
Generally, big investors with multi-billion dollar portfolios wait until the last possible date to release their 13F filing, which is not the case for Ken Fisher.
Keep Reading →
October 20 - Hedge Funds, News
Top best-selling products of all time: Some products come and go without much impact on society, yet others sell so well that they remain in our memories forever.
Keep Reading →
October 3 - Lists
Actavis plc (NYSE:ACT) is in hot water with the New York Attorney General’s office over practices they feel are manipulative of patients.
Keep Reading →
September 16 - News
AQR Capital Management, managed by Cliff Asness, recently published its 13F filing with the U.S. Securities and Exchange Commission for the second quarter of 2014.
Keep Reading →
August 18 - Hedge Funds, News
Matthew Tewksbury’s Stevens Capital Management recently disclosed, with the SEC, its long equity positions for the second quarter of 2014.
Keep Reading →
August 12 - Hedge Funds, News
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc.
Keep Reading →
July 29 - News
CNBC's Meg Tirrell reported on the popular “Squawk Box” program that patients suffering from Alzheimer disease in U.S and across the globe are assuming epidemic proportions...
Keep Reading →
July 11 - News
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Keep Reading →
January 17 - Hedge Funds, News
Chemical nerve agents have garnered much media coverage recently, but receiving less attention are the companies involved in the development of countermeasures to these and biological...
Keep Reading →
September 23 - News
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
Keep Reading →
September 17 - News
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Keep Reading →
September 17 - News
Lehman Brothers filed for bankruptcy protection early in the morning on Sept. 15, 2008, after failing to find any company willing to acquire its immense liabilities.
Keep Reading →
September 16 - News
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Keep Reading →
September 16 - News
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Keep Reading →
September 15 - News
In a couple of years, Amgen, Inc. (NASDAQ:AMGN) will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe.
Keep Reading →
September 12 - News
MannKind Corporation (NASDAQ:MNKD) has been struggling to get its inhalable insulin product Afrezza on the market; the product was sent back to the labs by the Food and Drug Administration...
Keep Reading →
September 12 - News
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
Keep Reading →
September 12 - News
Johnson & Johnson (NYSE:JNJ) recently announced a recall of around 200,000 bottles of Motrin Infants' Drops Original Berry Flavor.
Keep Reading →
September 11 - News
